Jon Glass

7.4k total citations
68 papers, 2.8k citations indexed

About

Jon Glass is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Jon Glass has authored 68 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Genetics, 27 papers in Pulmonary and Respiratory Medicine and 23 papers in Neurology. Recurrent topics in Jon Glass's work include Glioma Diagnosis and Treatment (44 papers), Brain Metastases and Treatment (25 papers) and CNS Lymphoma Diagnosis and Treatment (15 papers). Jon Glass is often cited by papers focused on Glioma Diagnosis and Treatment (44 papers), Brain Metastases and Treatment (25 papers) and CNS Lymphoma Diagnosis and Treatment (15 papers). Jon Glass collaborates with scholars based in United States, Israel and China. Jon Glass's co-authors include Fred H. Hochberg, Michael L. Gruber, Lawrence Cher, David W. Andrews, Maria Werner‐Wasik, James J. Evans, A Marx, Roland W. Sutter, Colin E. Champ and J. C. McArthur and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Neurology.

In The Last Decade

Jon Glass

65 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jon Glass United States 27 1.4k 1.0k 626 571 559 68 2.8k
Roelien H. Enting Netherlands 25 1.9k 1.3× 659 0.6× 409 0.7× 935 1.6× 467 0.8× 72 3.3k
Jack Rock United States 35 1.1k 0.8× 381 0.4× 800 1.3× 857 1.5× 523 0.9× 126 3.9k
Massimo Gerosa Italy 32 832 0.6× 1.0k 1.0× 302 0.5× 562 1.0× 1.1k 1.9× 126 3.0k
John W. Henson United States 33 1.6k 1.1× 623 0.6× 293 0.5× 881 1.5× 389 0.7× 83 3.7k
R Rampling United Kingdom 23 704 0.5× 477 0.5× 359 0.6× 372 0.7× 581 1.0× 49 2.7k
Jesse J. Jenkins United States 42 1.2k 0.8× 1.0k 1.0× 501 0.8× 1.9k 3.3× 565 1.0× 120 4.3k
Maria Luisa Garrè Italy 33 2.0k 1.4× 957 0.9× 216 0.3× 582 1.0× 563 1.0× 136 3.7k
Lawrence E. Ginsberg United States 41 510 0.4× 502 0.5× 382 0.6× 1.1k 1.8× 749 1.3× 150 4.8k
Michael Gonzales Australia 25 795 0.6× 680 0.7× 251 0.4× 226 0.4× 452 0.8× 86 2.0k
Michael Safaee United States 28 897 0.6× 536 0.5× 628 1.0× 335 0.6× 486 0.9× 130 2.9k

Countries citing papers authored by Jon Glass

Since Specialization
Citations

This map shows the geographic impact of Jon Glass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Glass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Glass more than expected).

Fields of papers citing papers by Jon Glass

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Glass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Glass. The network helps show where Jon Glass may publish in the future.

Co-authorship network of co-authors of Jon Glass

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Glass. A scholar is included among the top collaborators of Jon Glass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Glass. Jon Glass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yi, Ying Wu, Jingru Jiang, et al.. (2022). Efficacy and Safety of Apatinib for Radiation-induced Brain Injury Among Patients With Head and Neck Cancer: An Open-Label, Single-Arm, Phase 2 Study. International Journal of Radiation Oncology*Biology*Physics. 113(4). 796–804. 8 indexed citations
2.
Zhao, Chunling, Liang Fang, Samir Dalia, et al.. (2022). The m6A methyltransferase WTAP plays a key role in the development of diffuse large B-cell lymphoma via regulating the m6A modification of catenin beta 1. Annals of Translational Medicine. 10(14). 779–779. 7 indexed citations
3.
Song, Andrew, Voichita Bar‐Ad, Nina Martinez, et al.. (2020). Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma. Journal of Neuro-Oncology. 147(3). 653–661. 20 indexed citations
4.
Palmer, Joshua D., Deepak Bhamidipati, Gaurav Shukla, et al.. (2020). Outcomes after stereotactic radiosurgery for CNS lymphoma. Journal of Neuro-Oncology. 147(2). 465–476. 8 indexed citations
5.
Martinez, Nina, Jon Glass, & Wenyin Shi. (2019). Bevacizumab in recurrent glioblastoma. Translational Cancer Research. 8(2).
6.
Song, Andrew, David W. Andrews, Maria Werner‐Wasik, et al.. (2019). Phase I trial of alisertib with concurrent fractionated stereotactic re-irradiation for recurrent high grade gliomas. Radiotherapy and Oncology. 132. 135–141. 24 indexed citations
7.
Palmer, Joshua D., Deepak Bhamidipati, Andrew Song, et al.. (2018). Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?. Journal of Neuro-Oncology. 140(3). 623–628. 31 indexed citations
8.
Shi, Wenyin, Erik Blomain, Joshua Siglin, et al.. (2017). Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment. Journal of Neuro-Oncology. 137(1). 171–177. 11 indexed citations
9.
Shi, Wenyin, Joshua D. Palmer, Maria Werner‐Wasik, et al.. (2016). Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas. Journal of Neuro-Oncology. 127(3). 535–539. 41 indexed citations
10.
Champ, Colin E., Joshua D. Palmer, Jeff S. Volek, et al.. (2014). Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme. Journal of Neuro-Oncology. 117(1). 125–131. 170 indexed citations
11.
Lawrence, Yaacov Richard, Mark V. Mishra, Maria Werner‐Wasik, et al.. (2011). Improving prognosis of glioblastoma in the 21st century: Who has benefited most?. Cancer. 118(17). 4228–4234. 41 indexed citations
12.
Wuthrick, Evan, Mitchell Kamrava, Walter J. Curran, et al.. (2011). A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies. Cancer. 117(24). 5548–5559. 29 indexed citations
13.
Fogh, Shannon, David W. Andrews, Jon Glass, et al.. (2010). Hypofractionated Stereotactic Radiation Therapy: An Effective Therapy for Recurrent High-Grade Gliomas. Journal of Clinical Oncology. 28(18). 3048–3053. 254 indexed citations
14.
Eade, Thomas, Daniel F. Brown, Michael Weaver, et al.. (2007). RADIATION-INDUCED TUMOR AFTER STEREOTACTIC RADIOSURGERY FOR AN ARTERIOVENOUS MALFORMATION. Neurosurgery. 61(5). E1099–E1099. 39 indexed citations
15.
Rosenthal, Mark, Michael L. Gruber, Jon Glass, et al.. (2000). Phase II Study of Combination Taxol and Estramustine Phosphate in the Treatment of Recurrent Glioblastoma Multiforme. Journal of Neuro-Oncology. 47(1). 59–63. 17 indexed citations
16.
Gruber, Michael L., Jon Glass, Haroon F. Choudhri, & Anita Nirenberg. (1998). Carboplatin Chemotherapy Before Irradiation in Newly Diagnosed Glioblastoma Multiforme. American Journal of Clinical Oncology. 21(4). 338–340. 18 indexed citations
17.
Davies, Julia, Ian Everall, Scott Weich, et al.. (1998). HIV‐associated brain pathology: a comparative international study. Neuropathology and Applied Neurobiology. 24(2). 118–124. 22 indexed citations
18.
19.
Glass, Jon, et al.. (1993). Intravascular lymphomatosis a systemic disease with neurologic manifestations. Cancer. 71(10). 3156–3164. 177 indexed citations
20.
Glass, Jon, et al.. (1992). The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy. Journal of neurosurgery. 76(5). 741–745. 158 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roelien H. Enting Breakdown of academic impact, for papers by Jack Rock Breakdown of academic impact, for papers by Massimo Gerosa Breakdown of academic impact, for papers by John W. Henson Breakdown of academic impact, for papers by R Rampling Breakdown of academic impact, for papers by Jesse J. Jenkins Breakdown of academic impact, for papers by Maria Luisa Garrè Breakdown of academic impact, for papers by Lawrence E. Ginsberg Breakdown of academic impact, for papers by Michael Gonzales Breakdown of academic impact, for papers by Michael Safaee
Rankless by CCL
2026